231 related articles for article (PubMed ID: 23821607)
1. Evolutionary dynamics of the human NADPH oxidase genes CYBB, CYBA, NCF2, and NCF4: functional implications.
Tarazona-Santos E; Machado M; Magalhães WC; Chen R; Lyon F; Burdett L; Crenshaw A; Fabbri C; Pereira L; Pinto L; Redondo RA; Sestanovich B; Yeager M; Chanock SJ
Mol Biol Evol; 2013 Sep; 30(9):2157-67. PubMed ID: 23821607
[TBL] [Abstract][Full Text] [Related]
2. Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update).
Roos D; van Leeuwen K; Hsu AP; Priel DL; Begtrup A; Brandon R; Rawat A; Vignesh P; Madkaikar M; Stasia MJ; Bakri FG; de Boer M; Roesler J; Köker N; Köker MY; Jakobsen M; Bustamante J; Garcia-Morato MB; Shephard JLV; Cagdas D; Tezcan I; Sherkat R; Mortaz E; Fayezi A; Shahrooei M; Wolach B; Blancas-Galicia L; Kanegane H; Kawai T; Condino-Neto A; Vihinen M; Zerbe CS; Holland SM; Malech HL; Gallin JI; Kuhns DB
Blood Cells Mol Dis; 2021 Dec; 92():102596. PubMed ID: 34547651
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of autosomal recessive chronic granulomatous disease in iran.
Teimourian S; de Boer M; Roos D
J Clin Immunol; 2010 Jul; 30(4):587-92. PubMed ID: 20407811
[TBL] [Abstract][Full Text] [Related]
4. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly.
Leusen JH; Meischl C; Eppink MH; Hilarius PM; de Boer M; Weening RS; Ahlin A; Sanders L; Goldblatt D; Skopczynska H; Bernatowska E; Palmblad J; Verhoeven AJ; van Berkel WJ; Roos D
Blood; 2000 Jan; 95(2):666-73. PubMed ID: 10627478
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Modalities Based on Flow Cytometry for Chronic Granulomatous Disease: A Multicenter Study in a Well-Defined Cohort.
Baris HE; Ogulur I; Akcam B; Kiykim A; Karagoz D; Saraymen B; Akgun G; Eltan SB; Aydemir S; Akidagi Z; Bentli E; Nain E; Kasap N; Baser D; Altintas DU; Camcioglu Y; Yesil G; Ozen A; Koker MY; Karakoc-Aydiner E; Baris S
J Allergy Clin Immunol Pract; 2020; 8(10):3525-3534.e1. PubMed ID: 32736065
[TBL] [Abstract][Full Text] [Related]
6. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update).
Roos D; Kuhns DB; Maddalena A; Bustamante J; Kannengiesser C; de Boer M; van Leeuwen K; Köker MY; Wolach B; Roesler J; Malech HL; Holland SM; Gallin JI; Stasia MJ
Blood Cells Mol Dis; 2010 Apr; 44(4):291-9. PubMed ID: 20167518
[TBL] [Abstract][Full Text] [Related]
7. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity.
Matute JD; Arias AA; Wright NA; Wrobel I; Waterhouse CC; Li XJ; Marchal CC; Stull ND; Lewis DB; Steele M; Kellner JD; Yu W; Meroueh SO; Nauseef WM; Dinauer MC
Blood; 2009 Oct; 114(15):3309-15. PubMed ID: 19692703
[TBL] [Abstract][Full Text] [Related]
8. Three novel mutations in CYBA among 22 Iranians with Chronic granulomatous disease.
Badalzadeh M; Tajik S; Fazlollahi MR; Houshmand M; Fattahi F; Alizadeh Z; Movahedi M; Adab Z; Khotaei GT; Hamidieh AA; Heidarnazhad H; Pourpak Z
Int J Immunogenet; 2017 Dec; 44(6):314-321. PubMed ID: 28941186
[TBL] [Abstract][Full Text] [Related]
9. Role of Flow Cytometry in the Diagnosis of Chronic Granulomatous Disease: the Egyptian Experience.
El Hawary R; Meshaal S; Deswarte C; Galal N; Abdelkawy M; Alkady R; Elaziz DA; Freiberger T; Ravcukova B; Litzman J; Bustamante J; Boutros J; Gaafar T; Elmarsafy A
J Clin Immunol; 2016 Aug; 36(6):610-8. PubMed ID: 27222152
[TBL] [Abstract][Full Text] [Related]
10. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
[TBL] [Abstract][Full Text] [Related]
11. Second Report of Chronic Granulomatous Disease in Jordan: Clinical and Genetic Description of 31 Patients From 21 Different Families, Including Families From Lybia and Iraq.
Bakri FG; Mollin M; Beaumel S; Vigne B; Roux-Buisson N; Al-Wahadneh AM; Alzyoud RM; Hayajneh WA; Daoud AK; Shukair MEA; Karadshe MF; Sarhan MM; Al-Ramahi JAW; Fauré J; Rendu J; Stasia MJ
Front Immunol; 2021; 12():639226. PubMed ID: 33746979
[TBL] [Abstract][Full Text] [Related]
12. Chronic granulamatous disease: Two decades of experience from a paediatric immunology unit in a country with high rate of consangineous marriages.
Kutukculer N; Aykut A; Karaca NE; Durmaz A; Aksu G; Genel F; Pariltay E; Cogulu Ö; Azarsız E
Scand J Immunol; 2019 Feb; 89(2):e12737. PubMed ID: 30506560
[TBL] [Abstract][Full Text] [Related]
13. A Novel CYBB Mutation in Chronic Granulomatous Disease in Iran.
Tajik S; Badalzadeh M; Fazlollahi MR; Houshmand M; Zandieh F; Khandan S; Pourpak Z
Iran J Allergy Asthma Immunol; 2016 Oct; 15(5):426-429. PubMed ID: 27917630
[TBL] [Abstract][Full Text] [Related]
14. Genetic disorders coupled to ROS deficiency.
O'Neill S; Brault J; Stasia MJ; Knaus UG
Redox Biol; 2015 Dec; 6():135-156. PubMed ID: 26210446
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.
Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA
J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359
[TBL] [Abstract][Full Text] [Related]
16. The three CYBA variants (rs4673, rs1049254 and rs1049255) are benign: new evidence from a patient with CGD.
Sun J; Wen M; Wang Y; Liu D; Ying W; Wang X
BMC Med Genet; 2017 Nov; 18(1):127. PubMed ID: 29132304
[TBL] [Abstract][Full Text] [Related]
17. Point mutations in the promoter region of the CYBB gene leading to mild chronic granulomatous disease.
Weening RS; De Boer M; Kuijpers TW; Neefjes VM; Hack WW; Roos D
Clin Exp Immunol; 2000 Dec; 122(3):410-7. PubMed ID: 11122248
[TBL] [Abstract][Full Text] [Related]
18. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency.
Ishibashi F; Nunoi H; Endo F; Matsuda I; Kanegasaki S
Hum Genet; 2000 May; 106(5):473-81. PubMed ID: 10914676
[TBL] [Abstract][Full Text] [Related]
19. Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties.
Wolach B; Broides A; Zeeli T; Gavrieli R; de Boer M; van Leeuwen K; Levy J; Roos D
J Clin Immunol; 2011 Aug; 31(4):560-6. PubMed ID: 21604087
[TBL] [Abstract][Full Text] [Related]
20. Hematologically important mutations: X-linked chronic granulomatous disease (third update).
Roos D; Kuhns DB; Maddalena A; Roesler J; Lopez JA; Ariga T; Avcin T; de Boer M; Bustamante J; Condino-Neto A; Di Matteo G; He J; Hill HR; Holland SM; Kannengiesser C; Köker MY; Kondratenko I; van Leeuwen K; Malech HL; Marodi L; Nunoi H; Stasia MJ; Ventura AM; Witwer CT; Wolach B; Gallin JI
Blood Cells Mol Dis; 2010 Oct; 45(3):246-65. PubMed ID: 20729109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
